{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:37Z","timestamp":1791357397726,"version":"4.3.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1331\/japha.2012.12051","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T23:44:22Z","timestamp":1355183062000},"page":"e210-e219","source":"Crossref","is-referenced-by-count":79,"title":["Histamine-1 receptor antagonism for\u00a0treatment of insomnia"],"prefix":"10.1016","volume":"52","author":[{"given":"Joseph P.","family":"Vande Griend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2012.12051_bb0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.130.1.276","article-title":"Recent developments in the classification, evaluation, and treatment of insomnia","volume":"130","author":"Summers","year":"2006","journal-title":"Chest"},{"key":"10.1331\/JAPhA.2012.12051_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/smrv.2002.0186","article-title":"Epidemiology of insomnia: what we know and what we still need to learn","volume":"6","author":"Ohayon","year":"2002","journal-title":"Sleep Med Rev"},{"key":"10.1331\/JAPhA.2012.12051_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/14656566.9.3.351","article-title":"Pharmacotherapy of insomnia","volume":"9","author":"Bhat","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1331\/JAPhA.2012.12051_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/sleep\/30.3.263","article-title":"The direct and indirect costs of untreated insomnia in adults in the United States","volume":"30","author":"Ozminkowski","year":"2007","journal-title":"Sleep"},{"issue":"suppl 2","key":"10.1331\/JAPhA.2012.12051_bb0030","first-page":"S386","article-title":"The direct economic costs of insomnia in the United States for 1995","volume":"22","author":"Walsh","year":"1999","journal-title":"Sleep"},{"key":"10.1331\/JAPhA.2012.12051_bb0035","series-title":"Stahl's essential psychopharmacology","author":"Stahl","year":"2008"},{"key":"10.1331\/JAPhA.2012.12051_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2003.10.031","article-title":"Wakefulness-inducing effects of histamine in the basal forebrain of freely moving rats","volume":"152","author":"Ramesh","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1331\/JAPhA.2012.12051_bb0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0306-4522(02)00158-6","article-title":"Extracellular histamine levels in the feline preoptic\/anterior hypothalamic area during natural sleep-wakefulness and prolonged wakefulness: an in vivo microdialysis study","volume":"113","author":"Strecker","year":"2002","journal-title":"Neuroscience"},{"key":"10.1331\/JAPhA.2012.12051_bb0050","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.2165\/0003495-200868170-00001","article-title":"Antidepressants for the treatment of insomnia: a suitable approach?","volume":"68","author":"Wiegand","year":"2008","journal-title":"Drugs"},{"key":"10.1331\/JAPhA.2012.12051_bb0055","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1017\/S1092852900017089","article-title":"Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines","volume":"13","author":"Stahl","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1331\/JAPhA.2012.12051_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1087-0792(03)00042-X","article-title":"The treatment of chronic insomnia: drug indications, chronic use and abuse liability: summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium","volume":"8","author":"Mendelson","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1331\/JAPhA.2012.12051_bb0065","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J Clin Sleep Med"},{"key":"10.1331\/JAPhA.2012.12051_bb0070","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/sleep\/28.11.1465","article-title":"Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial","volume":"28","author":"Morin","year":"2005","journal-title":"Sleep"},{"key":"10.1331\/JAPhA.2012.12051_bb0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/JCP.0b013e31816a9e4f","article-title":"Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial","volume":"28","author":"Glass","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1331\/JAPhA.2012.12051_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/j.1552-4604.1983.tb02730.x","article-title":"Diphenhydramine in insomniac family practice patients: a double-blind study","volume":"23","author":"Rickels","year":"1983","journal-title":"J Clin Pharmacol"},{"key":"10.1331\/JAPhA.2012.12051_bb0085","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/106002808702100908","article-title":"Evaluation of temazepam and diphenhydramine as hypnotics in a nursing-home population","volume":"21","author":"Meuleman","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1331\/JAPhA.2012.12051_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/cpt196781part148","article-title":"The hypnotic efficacy of doxylamine","volume":"8","author":"Sjoqvist","year":"1967","journal-title":"Clin Pharmacol Ther"},{"key":"10.1331\/JAPhA.2012.12051_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-3223(00)00882-9","article-title":"Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study","volume":"48","author":"Winokur","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1331\/JAPhA.2012.12051_bb0100","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4088\/JCP.v64n1013","article-title":"Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia","volume":"64","author":"Winokur","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1331\/JAPhA.2012.12051_bb0105","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00520-008-0425-1","article-title":"Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine","volume":"16","author":"Cankurtaran","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1331\/JAPhA.2012.12051_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-1819.2007.01778.x","article-title":"Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression","volume":"62","author":"Kim","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1331\/JAPhA.2012.12051_bb0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00004714-200010000-00006","article-title":"Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens","volume":"20","author":"Radhakishun","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1331\/JAPhA.2012.12051_bb0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF00278580","article-title":"Effect of the antidepressant Org 3770 on human sleep","volume":"38","author":"Ruigt","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1331\/JAPhA.2012.12051_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370605100106","article-title":"Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine","volume":"51","author":"Shen","year":"2006","journal-title":"Can J Psychiatry"},{"key":"10.1331\/JAPhA.2012.12051_bb0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000067812","article-title":"Effects of mirtazapine on sleep polygraphic variables in major depression","volume":"46","author":"Schittecatte","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1331\/JAPhA.2012.12051_bb0135","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/sleep\/25.6.666","article-title":"The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers","volume":"25","author":"Aslan","year":"2002","journal-title":"Sleep"},{"key":"10.1331\/JAPhA.2012.12051_bb0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.jcp.0000085411.08426.d3","article-title":"Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations","volume":"23","author":"Bon O","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1331\/JAPhA.2012.12051_bb0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1099-1077(199804)13:3<191::AID-HUP972>3.0.CO;2-X","article-title":"Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia","volume":"13","author":"Walsh","year":"1998","journal-title":"Human Psychopharmacol"},{"key":"10.1331\/JAPhA.2012.12051_bb0150","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2869.2011.00928.x","article-title":"Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs","volume":"20","author":"Roth","year":"2011","journal-title":"J Sleep Res"},{"key":"10.1331\/JAPhA.2012.12051_bb0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drugalcdep.2011.06.026","article-title":"Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial","volume":"120","author":"Stein","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1331\/JAPhA.2012.12051_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2002-34119","article-title":"Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study","volume":"35","author":"Riemann","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1331\/JAPhA.2012.12051_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4088\/JCP.v62n0609","article-title":"Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study","volume":"62","author":"Hajak","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1331\/JAPhA.2012.12051_bb0170","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/sleep\/30.11.1555","article-title":"Efficacy and safety of doxepin 1mg, 3mg, and 6mg in adults with primary insomnia","volume":"30","author":"Roth","year":"2007","journal-title":"Sleep"},{"key":"10.1331\/JAPhA.2012.12051_bb0175","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4088\/JCP.v69n1005","article-title":"Efficacy and safety of doxepin 1mg, 3mg, and 6mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study","volume":"69","author":"Scharf","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1331\/JAPhA.2012.12051_bb0180","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/sleep\/33.11.1553","article-title":"Efficacy and safety of doxepin 1mg and 3mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia","volume":"33","author":"Krystal","year":"2010","journal-title":"Sleep"},{"key":"10.1331\/JAPhA.2012.12051_bb0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.sleep.2010.07.006","article-title":"Efficacy and safety of doxepin 6mg in a model of transient insomnia","volume":"11","author":"Roth","year":"2010","journal-title":"Sleep Med"},{"key":"10.1331\/JAPhA.2012.12051_bb0190","first-page":"1433","article-title":"Efficacy and safety of doxepin 3 and 6mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia","volume":"34","author":"Krystal","year":"2011","journal-title":"Sleep"},{"key":"10.1331\/JAPhA.2012.12051_bb0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sleep.2011.09.006","article-title":"Efficacy and safety of doxepin 6mg in a four-week outpatient trial of elderly adults with chronic primary insomnia","volume":"13","author":"Lankford","year":"2011","journal-title":"Sleep Med"},{"key":"10.1331\/JAPhA.2012.12051_bb0200","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"60","author":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1331\/JAPhA.2012.12051_bb0205","author":"Micromedex Healthcare Series"},{"key":"10.1331\/JAPhA.2012.12051_bb0210","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0091-6749(94)90179-1","article-title":"Sleepiness and performance during three-day administration of cetirizine or diphenhydramine","volume":"94","author":"Schweitzer","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1331\/JAPhA.2012.12051_bb0215","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/j.1552-4604.1992.tb03801.x","article-title":"Central nervous system effects of meclizine and dimenhydrinate: evidence of acute tolerance to antihistamines","volume":"32","author":"Manning","year":"1992","journal-title":"J Clin Pharmacol"},{"key":"10.1331\/JAPhA.2012.12051_bb0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00609857","article-title":"Evidence for tolerance to the central nervous effects of the histamine antagonist, triprolidine, in man","volume":"12","author":"Bye","year":"1977","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1331\/JAPhA.2012.12051_bb0225","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF00626365","article-title":"Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine","volume":"41","author":"Levander","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1331\/JAPhA.2012.12051_bb0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00023210-200013020-00002","article-title":"Histamine H1 receptor antagonists in the treatment of insomnia: is there a rational basis for use?","volume":"13","author":"Monti","year":"2000","journal-title":"CNS Drugs"},{"key":"10.1331\/JAPhA.2012.12051_bb0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/j.1875-9114.1997.tb03674.x","article-title":"Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects","volume":"17","author":"Stimmel","year":"1997","journal-title":"Pharmacotherapy"},{"issue":"suppl 17","key":"10.1331\/JAPhA.2012.12051_bb0240","first-page":"28","article-title":"Antidepressant treatment of the depressed patient with insomnia","volume":"60","author":"Thase","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1331\/JAPhA.2012.12051_bb0245","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1592\/phco.29.4.383","article-title":"Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly","volume":"29","author":"Fox","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1331\/JAPhA.2012.12051_bb0250","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.sleep.2009.09.012","article-title":"Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization","volume":"11","author":"Roy","year":"2010","journal-title":"Sleep Med"},{"key":"10.1331\/JAPhA.2012.12051_bb0255","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4088\/JCP.v66n0409","article-title":"A review of the evidence for the efficacy and safety of trazodone in insomnia","volume":"66","author":"Mendelson","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1331\/JAPhA.2012.12051_bb0260","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11606-007-0251-z","article-title":"The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs","volume":"22","author":"Buscemi","year":"2007","journal-title":"J Gen Intern Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115305872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115305872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T23:48:36Z","timestamp":1643845716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115305872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1544319115305872"],"URL":"https:\/\/doi.org\/10.1331\/japha.2012.12051","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}